According to a recent study, there are no associations between atopic dermatitis (AD) and cardiovascular risk factors in children and adolescents.
Concomitant topical insulin and microneedling may increase effectiveness of treatment in acne patients
According to a recent study, adjunct topical insulin alongside microneedling decreases the rate of poor improvement scores in acne vulgaris patients.
Alopecia areata linked to higher risk of AD in patients
According to a recent study, patients with moderate to severe alopecia areata (AA) have a higher risk of developing atopic dermatitis (AD).
Researchers develop nanoparticles to remove melanoma with low-power laser light
Researchers at Oregon State University have developed a new nanoparticle to allow the removal of melanoma tumours using low-power laser light.
Researchers develop dissolved bubble microneedle patch for acne vulgaris
Researchers have developed a dissolved bubble microneedle patch that simultaneously delivers hydrophilic and hydrophobic medications directly into the skin of acne vulgaris patients.
Researchers discover natural sunscreen compounds may also support skin and heart health
According to a recent study, natural compounds that can be used in sunscreens may also be beneficial for skin health and blood pressure.
mRNA therapy could decrease radiation-induced skin damage from cancer treatments
Researchers have discovered a new approach to protect patients from radiation-induced skin damage during cancer treatments.
Researchers review relative efficacy of immunomodulatory therapies for scalp PsO
Researchers recently reviewed the relative efficacy of 22 immunomodulatory treatments, including placebo, for the treatment of scalp psoriasis.
Healthy plant-based diet may be linked to decreased rosacea risk
According to a recent study, healthy diets full of plant-based foods have been shown to decrease the risk of rosacea.
Researchers evaluate effectiveness of biologics on bio-naïve and bio-experienced PsO patients
In a recent study, researchers identify biologics for psoriasis that have better drug survival in bio-naïve or bio-experienced patients—a finding they hope can guide treatment choice in clinical practice.
